RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hyundai Bioscience Co Stock

Hyundai Bioscience Co Equity 2024

Hyundai Bioscience Co Equity

0 KRW

Ticker

048410.KQ

ISIN

KR7048410005

In 2024, Hyundai Bioscience Co's equity was 0 KRW, a -100% increase from the 58.24 B KRW equity in the previous year.

Hyundai Bioscience Co Aktienanalyse

What does Hyundai Bioscience Co do?

Hyundai Bioscience Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Hyundai Bioscience Co's Equity

Hyundai Bioscience Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Hyundai Bioscience Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Hyundai Bioscience Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Hyundai Bioscience Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Hyundai Bioscience Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Hyundai Bioscience Co stock

What is the equity of Hyundai Bioscience Co this year?

Hyundai Bioscience Co has equity of 0 KRW this year.

What was the equity of Hyundai Bioscience Co compared to the previous year?

The equity of Hyundai Bioscience Co has increased/decreased by -100% decreased compared to the previous year.

What impact does a high equity have on investors of Hyundai Bioscience Co?

A high equity is advantageous for investors of Hyundai Bioscience Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Hyundai Bioscience Co?

A low equity can be a risk for investors of Hyundai Bioscience Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Hyundai Bioscience Co affect the company?

An increase in equity of Hyundai Bioscience Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Hyundai Bioscience Co affect the company?

A reduction in equity of Hyundai Bioscience Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Hyundai Bioscience Co?

Some factors that can affect the equity of Hyundai Bioscience Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Hyundai Bioscience Co so important for investors?

The equity of Hyundai Bioscience Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Hyundai Bioscience Co take to change the equity?

To change equity, Hyundai Bioscience Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Hyundai Bioscience Co pay?

Over the past 12 months, Hyundai Bioscience Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hyundai Bioscience Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Hyundai Bioscience Co?

The current dividend yield of Hyundai Bioscience Co is .

When does Hyundai Bioscience Co pay dividends?

Hyundai Bioscience Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hyundai Bioscience Co?

Hyundai Bioscience Co paid dividends every year for the past 0 years.

What is the dividend of Hyundai Bioscience Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hyundai Bioscience Co located?

Hyundai Bioscience Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Hyundai Bioscience Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hyundai Bioscience Co from 4/13/2004 amounting to 50 KRW, you needed to have the stock in your portfolio before the ex-date on 12/29/2003.

When did Hyundai Bioscience Co pay the last dividend?

The last dividend was paid out on 4/13/2004.

What was the dividend of Hyundai Bioscience Co in the year 2023?

In the year 2023, Hyundai Bioscience Co distributed 0 KRW as dividends.

In which currency does Hyundai Bioscience Co pay out the dividend?

The dividends of Hyundai Bioscience Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hyundai Bioscience Co

Our stock analysis for Hyundai Bioscience Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hyundai Bioscience Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.